Abstract

Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality

Author(s): Hagan John C III, Everett Eric, Chamberlain Tyler

Issue: May/Jun 2020 - Volume 24, Number 3

Page(s): 194-197

Download in electronic PDF format for $75

Note: Electronic version includes supplemental material.

Abstract

Beta blockers (timolol 0.5% ophthalmic solution) delivered topically to the eyes or sublingually have recently been reported in case series and small placebo controlled studies to be effective in some cases of acute migraine. Rapid systemic absorption to achieve therapeutic levels of beta blockers is extremely important in the treatment of acute migraine. Nasal delivered beta blockers have been shown to be absorbed as fast as intravenous administration and seem ideal for acute migraine treatment. A nasal delivered beta-blocker spray has not been available. In 2019, O’Brien Pharmacy prepared a compounded timolol nasal spray that is now available to authorized prescribers. The theoretical basis for using nasal beta blocker spray is presented and research on fast-acting beta-blocker solutions for acute migraine is reviewed.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2020 Pg. 194-197	Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality Author(s): Hagan John C III, Everett Eric, Chamberlain Tyler
Mar/Apr 2024 Pg. 129	Addendum to Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine A New Therapeutic Modality Author(s):
Sep/Oct 2022 Pg. 364-368	A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Author(s): Riepl Mike
Mar/Apr 2023 Pg. 153	Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 328-332	Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Jul/Aug 2024 Pg. 286-290	Acute Migraine Treatment with Timolol 0.5% Nasal Spray - Compounding Pharmacists Have an Important Role Author(s): Hagan John C III, Kosa Steven C, Chamberlain Tyler
Nov/Dec 2011 Pg. 458-463	Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Author(s): Zur Eyal
Jul/Aug 2025 Pg. 259-266	Compounding Pharmacists: Key Educators on Timolol Nasal Spray for Acute Migraine Author(s): Hagan John C
Jul/Aug 2017 Pg. 282-289	Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Author(s): Choo Winnie
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2007 Pg. 520-524	Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2012 Pg. 270-274	A Concise Discussion of Headache Types, Part 3: Migraine Author(s): Williams LaVonn A, Allen Loyd V Jr
Sep/Oct 2000 Pg. 342	Compounding with Beta-1, 3-D-Glucan Author(s): Keller Ted
Mar/Apr 2016 Pg. 147	Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 150	Prochlorperazine Edisylate 0.5% Nasal Spray Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 418-419	Ipratropium Bromide 0.05% Nasal Spray Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 57	Sodium Citrate 9% Nasal Spray for Olfactory Disorders Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 229	Dexpanthenol 5% Nasal Spray Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 506-515	Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Author(s): Mixon William, Angelle Patricea (Patsy), Chang Richard I
May/Jun 2013 Pg. 233	Labetalol 50-mg Capsules Author(s): Allen Loyd V Jr